Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 337-347, March 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hard, G. C.
Right arrow Articles by Butler, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hard, G. C.
Right arrow Articles by Butler, W. H.

Ultrastructural Study of the Development of Interstitial Lesions Leading to Mesenchymal Neoplasia Induced in the Rat Renal Cortex by Dimethylnitrosamine

G. C. Hard and W. H. Butler

Medical Research Council Laboratories, Toxicology Unit, Woodmansterne Road, Carshalton, England

Within 24 hr following the administration of a single i.p. injection of dimethylnitrosamine in doses that result in up to 100% incidence of renal mesenchymal tumors, intracellular damage is seen with the electron microscope in interstitial cells with fibroblast morphology in the vicinity of glomeruli. Within several days of treatment, some periglomerular cortical fibrocytes and capillary endothelial cells are stimulated into division. An interstitial mononuclear inflammatory reaction, in which the macrophage is the dominant cell form, reaches a peak of intensity by 7 days. From 3 weeks on, a few glomerulus-associated hypercellular foci persist. The dominant cell type at this stage is the lymphocyte, although by 8 weeks plasma cells are also numerous. Abnormal fibroblast-like cells are noted in very small but increasing numbers within persisting lesions from 3 weeks after drug administration. By 12 weeks, there is a marked reduction of immunological cells, and persisting lesions consist predominantly of aggregations of fibroblast-like cells ultrastructurally identical with spindle or stellate cells of well-developed tumors. By 20 weeks, the proliferating lesions display the broad spectrum of vascular differentiation characteristic of these tumors. The findings are discussed with respect to the correlation between the target cell of acute injury and the ultimate development of neoplasm and the significance of abnormal cell forms present in early, persisting lesions.

Received 8/28/70. Accepted 10/21/70.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.